{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:52:25Z","timestamp":1792162345661,"version":"4.4.0"},"reference-count":17,"publisher":"Medknow","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["smedj"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.11622\/smedj.2019110","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T03:57:21Z","timestamp":1568865441000},"page":"149-153","source":"Crossref","is-referenced-by-count":38,"title":["Corticosteroid phobia: a questionnaire study using TOPICOP score"],"prefix":"10.4103","volume":"61","author":[{"given":"E","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NS","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2581","published-online":{"date-parts":[[2020,3]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0738-081X(02)00368-1","article-title":"The use of corticosteroids and corticosteroid phobia in atopic dermatitis","volume":"21","author":"Charman","year":"2003","unstructured":"1. Charman C, Williams H. The use of corticosteroids and corticosteroid phobia in atopic dermatitis. Clin Dermatol 2003; 21:193-200.","journal-title":"Clin Dermatol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1001\/jamadermatol.2017.2437","article-title":"Topical corticosteroid phobia in atopic dermatitis: a systematic review","volume":"153","author":"AW","year":"2017","unstructured":"2. Li AW, Yin ES, Antaya RJ. Topical corticosteroid phobia in atopic dermatitis: a systematic review. JAMA Dermatol 2017; 153:1036-42.","journal-title":"JAMA Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Moret L, Anthoine E, Aubert-Wastiaux H, et al. TOPICOP\u00a9: a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents. PLoS One 2013; 8:e76493.","DOI":"10.1371\/journal.pone.0076493"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1111\/all.13189","article-title":"Topical corticosteroid phobia in atopic dermatitis: international feasibility study of the TOPICOP score","volume":"72","author":"Stalder","year":"2017","unstructured":"4. Stalder JF, Aubert H, Anthoine E, et al. Topical corticosteroid phobia in atopic dermatitis: international feasibility study of the TOPICOP score. Allergy 2017; 72:1713-9.","journal-title":"Allergy"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s40257-017-0318-5","article-title":"Topical corticosteroid concerns among parents of children with psoriasis versus atopic dermatitis: a French multicenter cross-sectional study","volume":"19","author":"Moawad","year":"2018","unstructured":"5. Moawad S, Mah\u00e9 E, Aubert-Wastiaux H, et al. Topical corticosteroid concerns among parents of children with psoriasis versus atopic dermatitis: a French multicenter cross-sectional study. Am J Clin Dermatol 2018; 19:261-5.","journal-title":"Am J Clin Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1080\/09546634.2017.1306017","article-title":"Evaluation of the influence of family and friends, and the Internet on patient perceptions of long-term topical corticosteroid use","volume":"28","author":"Smith","year":"2017","unstructured":"6. Smith SD, Farrugia LL, Harris V, et al. Evaluation of the influence of family and friends, and the Internet on patient perceptions of long-term topical corticosteroid use. J Dermatol Treat 2017; 28:642-6.","journal-title":"J Dermatol Treat"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/ajd.12339","article-title":"Pharmacists' knowledge about use of topical corticosteroids in atopic dermatitis: pre and post continuing professional development education","volume":"57","author":"Smith","year":"2016","unstructured":"7. Smith SD, Lee A, Blaszczynski A, Fischer G. Pharmacists' knowledge about use of topical corticosteroids in atopic dermatitis: pre and post continuing professional development education. Australas J Dermatol 2016; 57:199-204.","journal-title":"Australas J Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/09546634.2016.1213353","article-title":"Evaluation of the influence of pharmacists and GPs on patient perceptions of long-term topical corticosteroid use","volume":"28","author":"Farrugia","year":"2017","unstructured":"8. Farrugia LL, Lee A, Fischer G, et al. Evaluation of the influence of pharmacists and GPs on patient perceptions of long-term topical corticosteroid use. J Dermatol Treat 2017; 28:112-8.","journal-title":"J Dermatol Treat"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.5021\/ad.2015.27.5.499","article-title":"Topical corticosteroid phobia among parents of children with atopic eczema in Korea","volume":"27","author":"Lee","year":"2015","unstructured":"9. Lee JY, Her Y, Kim CW, Kim SS. Topical corticosteroid phobia among parents of children with atopic eczema in Korea. Ann Dermatol 2015; 27:499-506.","journal-title":"Ann Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3109\/09546634.2015.1025030","article-title":"Correlations among steroid fear, acceptability, usage frequency, quality of life and disease severity in childhood eczema","volume":"26","author":"Hon","year":"2015","unstructured":"10. Hon KL, Tsang YC, Pong NH, et al. Correlations among steroid fear, acceptability, usage frequency, quality of life and disease severity in childhood eczema. J Dermatolog Treat 2015; 26:418-25.","journal-title":"J Dermatolog Treat"},{"key":"ref10","unstructured":"11. Huynh RK, Wong HH, Aw D, Toh MP. Adherence to topical corticosteroids and moisturisers in adults with endogenous eczema in Singapore. Hong Kong J Dermatol Venereol 2015; 23:161-74."},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Gonzales F, Ramdane N, Delebarre-Sauvage C, et al. Monitoring of topical corticosteroid phobia in a population of parents with children with atopic dermatitis using the TOPICOP\u00ae scale: prevalence, risk factors and the impact of therapeutic patient education. J Eur Acad Dermatol Venereol 2017; 31:e172-4.","DOI":"10.1111\/jdv.13961"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1525-1470.2012.01808.x","article-title":"Factors associated with steroid phobia in caregivers of children with atopic dermatitis","volume":"30","author":"Kojima","year":"2013","unstructured":"13. Kojima R, Fujiwara T, Matsuda A, et al. Factors associated with steroid phobia in caregivers of children with atopic dermatitis. Pediatr Dermatol 2013; 30:29-35.","journal-title":"Pediatr Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1159\/000446068","article-title":"Topical corticosteroid concerns in dermatological outpatients: a cross-sectional and interventional study","volume":"232","author":"M\u00fcller","year":"2016","unstructured":"14. M\u00fcller SM, Tomaschett D, Euler S, et al. Topical corticosteroid concerns in dermatological outpatients: a cross-sectional and interventional study. Dermatology 2016; 232:444-52.","journal-title":"Dermatology"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Gu S, Yang AW, Xue CC, et al. Chinese herbal medicine for atopic eczema. Cochrane Database Syst Rev 2013; (9):CD008642.","DOI":"10.1002\/14651858.CD008642.pub2"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1080\/09546634.2016.1214673","article-title":"Chinese herbal medicine for atopic eczema: an overview of clinical evidence","volume":"28","author":"SX","year":"2017","unstructured":"16. Gu SX, Zhang AL, Coyle ME, Chen D, Xue CC. Chinese herbal medicine for atopic eczema: an overview of clinical evidence. J Dermatolog Treat 2017; 28:246-50.","journal-title":"J Dermatolog Treat"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1046\/j.1365-2133.2000.03473.x","article-title":"Topical corticosteroid phobia in patients with atopic eczema","volume":"142","author":"Charman","year":"2000","unstructured":"17. Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 2000; 142:931-6.","journal-title":"Br J Dermatol"}],"container-title":["Singapore Medical Journal"],"original-title":[],"link":[{"URL":"http:\/\/www.smj.org.sg\/article\/corticosteroid-phobia-questionnaire-study-using-topicop-score","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T10:49:58Z","timestamp":1660042198000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.smj.org.sg\/article\/corticosteroid-phobia-questionnaire-study-using-topicop-score"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]},"published-print":{"date-parts":[[2020,3]]}},"URL":"https:\/\/doi.org\/10.11622\/smedj.2019110","relation":{},"ISSN":["0037-5675"],"issn-type":[{"value":"0037-5675","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}